ArticleAnnals of burns and fire disasters2026
[Bacteraemias due to Enterococci in Burns: Incidence and Factors Associated to Mortality].
Article in Annals of burns and fire disasters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Enterococcus species are a common cause of nosocomial bacteremia, affecting patients with severe comorbidities. They are often associated with significant morbidity and mortality. A prognostic, observational, mono-centric and retrospective study was conducted in the intensive burn care unit over 4 years, from January 2020 - December 2023. Burn patients who had at least one episode of Enterococcus spp. bacteremia were included. Out of 1,566 admitted patients, 102 developed at least one Enterococcus bacteremia (an incidence of 7.3%), of which 88 patients were retained for analysis. A total of 104 enterococcal bacteremias were observed. The most common species was E. fæcium (58.7%). Twenty-four percent of the strains were resistant to teicoplanin, and 28.8% were resistant to vancomycin. No resistance to tigecycline or linezolid was noted. The median time to the onset of bacteremia was 7 days, and it was complicated by septic shock in 40.4% of cases. Bacteremia was primitive in 96% of cases and polymicrobial in 78,8% of cases. Median ICU length of stay was 22 days. Mortality was 55.7%. Independent factors associated with mortality due to enterococcal bacteremia were: occurrence of ARDS (acute respiratory distress syndrome), acute renal failure, fungal infection, and Enterococcus resistance to vancomycin.
Indexed as
Identifiers
42370047PMC13296972What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.